PNC Financial Services Group’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3K | Buy |
1,537
+729
| +90% | +$7.27K | ﹤0.01% | 3693 |
|
|
2025
Q1 | $4.82K | Buy |
808
+790
| +4,389% | +$4.72K | ﹤0.01% | 4079 |
|
|
2024
Q4 | $138 | Sell |
18
-52
| -74% | -$399 | ﹤0.01% | 4689 |
|
|
2024
Q3 | $715 | Hold |
70
| – | – | ﹤0.01% | 4506 |
|
|
2024
Q2 | $1.04K | Buy |
70
+11
| +19% | +$163 | ﹤0.01% | 4414 |
|
|
2024
Q1 | $805 | Hold |
59
| – | – | ﹤0.01% | 4415 |
|
|
2023
Q4 | $646 | Sell |
59
-2,228
| -97% | -$24.4K | ﹤0.01% | 4374 |
|
|
2023
Q3 | $25K | Buy |
2,287
+1,299
| +131% | +$14.2K | ﹤0.01% | 3311 |
|
|
2023
Q2 | $13.1K | Buy |
988
+728
| +280% | +$9.64K | ﹤0.01% | 3751 |
|
|
2023
Q1 | $3.54K | Sell |
260
-1,427
| -85% | -$19.4K | ﹤0.01% | 4152 |
|
|
2022
Q4 | $32.9K | Sell |
1,687
-282
| -14% | -$5.51K | ﹤0.01% | 3221 |
|
|
2022
Q3 | $37K | Buy |
1,969
+358
| +22% | +$6.73K | ﹤0.01% | 3144 |
|
|
2022
Q2 | $34K | Buy |
1,611
+1,048
| +186% | +$22.1K | ﹤0.01% | 3218 |
|
|
2022
Q1 | $18K | Buy |
+563
| New | +$18K | ﹤0.01% | 3621 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | – | – | 4232 |
|
|
2021
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4155 |
|